CERU
Cerulean Pharma Inc.
Set alert
No live quote for CERU yet.
- Open
- 0.68
- Prev close
- 0.6309
- Mkt cap
- 19.04M
- Vol
- 6.24M
- Avg vol
- 217.76K
- EPS
- 0.00
- P/E
- -0.57
- Div yield
- 0.00%
More statistics
- Low
- 0.63
- High
- 0.88
- Forward P/E
- -1.06
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.88
- 200-d avg
- 8.34
- 1y target
- 3.75
Key statistics
- Market cap
- 19.04M
- Enterprise value
- 0
- Trailing P/E
- -0.57
- Forward P/E
- -1.06
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 6.88
- 200-day average
- 8.34
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 3.75
- Target (low)
- 1.50
- Target (mean)
- 3.75
- Target (high)
- 6.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 2016 | Wedbush | down | — | Neutral |
| Aug 17, 2016 | Leerink Swann | down | — | Market Perform |
| Aug 17, 2016 | Janney Capital | down | — | Neutral |
| Aug 17, 2016 | JMP Securities | down | — | Market Perform |
| Jan 5, 2016 | Janney Capital | init | — | Buy |
| Sep 21, 2015 | Barclays | init | — | Overweight |
News
Your note
Sign in to keep a note on CERU — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARBUCKLE STUART A | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 13,104 |
| FRIEDMAN PAUL A | Director | Acquisition (Non Open Market) | Apr 2, 2017 | 18,819 |
| GUIFFRE CHRISTOPHERD T | Officer | Acquisition (Non Open Market) | Dec 30, 2016 | 12,489 |
| MCKEE WILLIAM | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 3,418 |
| ONEILL JAMES E | Officer | Acquisition (Non Open Market) | Dec 30, 2015 | 2,098 |
| PARKINSON DAVID ROSS | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 28,488 |